network 13 home
providers
patients
FDA Medwatch
Complaints and Grievance Page
Dialysis Facility Compare
Patient Rights & Responsibilities
Disaster Readiness
Network Patient
Representative Program
Upcoming Events for Patients
Other Patient Resources
Patient Advocacy Committee
Kidney Community Gatherings
Returning to Work (Vocational Rehabilitation)
Patient Newsletter
Medicare Information
Support Groups
Contact Us
ESRD Network 13 Medwatch Database
To Search the ESRD Network 13 FDA Medwatch Database click
here
.
ESRD's FDA Medwatch Listing
04/23/2013
FDA MedWatch - CareFusion Alaris PC Unit with Software V9.12: Class 1 Recall - Communication Error When Attached to EtCO2 or SpO2 Modules
04/22/2013
FDA MedWatch - Balanced Solutions All Sterile Compounded Products: Recall - Lack of Sterility Assurance
04/15/2013
FDA MedWatch - March 2013 Safety Labeling Changes includes 53 products with revisions to Prescribing Information
04/05/2013
FDA MedWatch - Animas Corporation 2020 Insulin Infusion Pump: Class I Recall - False Alarm or Warning Sound
04/01/2013
FDA MedWatch - Sodium Chloride Injection, 0.9 percent, 1000 mL, Flexible Container: Recall - Brass Particulates
03/27/2013
FDA MedWatch - Palimed Solutions, Inc. Sterile Compound Products: Recall - Visible Particulates Observed
03/15/2013
FDA MedWatch - Incretin Mimetic Drugs for Type 2 Diabetes: Early Communication - Reports of Possible Increased Risk of Pancreatitis and Pre-cancerous Findings of the Pancreas
03/12/2013
FDA MedWatch - Azithromycin (Zithromax or Zmax): Drug Safety Communication - Risk of Potentially Fatal Heart Rhythms
03/12/2013
FDA MedWatch - February 2013 Safety Labeling Changes includes 35 products with revisions to Prescribing Information
02/26/2013
FDA MedWatch - Sensipar (Cinacalcet Hydrochloride): Drug Safety Communication - FDA Suspends Pediatric Clinical Trials After Report Of Death
First
Previous
Next
Last